Author:
Titos-Arcos J.C.,León-Villar J.,de Arriba de la Fuente F.,Moreno Belmonte M.J.,Iranzo Fernández M.D.
Reference30 articles.
1. Indicaciones y resultados clínicos con el inhibidor del proteasoma, bortezomib, en el tratamiento del mieloma múltiple;Mateos;Haematologica,2005
2. Proteasome inhibition as a novel therapeutic target in human cancer;Rajkumar;J Clin Oncol,2005
3. Therapy with bortezomib plus dexamethasone induces osteoblast activation in responsive patients with multiple myeloma;Ozaki;Int J Hematol,2007
4. Ficha técnica de Velcade® (bortezomib). Laboratorio Jansen-Cilag [consultado 22 Dic 2010]. Disponible en: http://www.ema.europa.eu/docs/es_ES/document_library/EPAR_-Product_Information/human/oo539/WC500048471.pdf.
5. Bortezomib for the treatment of mantle cell lymphoma;Kane;Clin Cancer Res,2007